Reversible Arthritis in Adult Patients: Pathophysiology, Therapeutic Approaches, and Prognostic Factors
Keywords:
Clinical improvement, C-reactive protein (CRP), Inflammatory arthritis, NSAIDs, Pain score, Reversible arthritis, Uric acidAbstract
Reversible arthritis describes inflammatory joint conditions in which pain, swelling, stiffness, and functional impairment may substantially improve when the underlying inflammatory process is recognized and treated at an early stage. Unlike established chronic arthropathies associated with progressive structural damage, some acute inflammatory joint conditions may resolve without permanent functional impairment when appropriate treatment is initiated promptly. The present prospective clinical observational study evaluated the clinical presentation, selected biochemical markers, treatment response, and short-term outcomes among 50 adult female patients with clinical features consistent with reversible inflammatory arthritis. The mean age of the participants was approximately 50 years. Patients presented primarily with joint pain, inflammation, and functional limitation. Daily pain scores were recorded using a 1–10 scale, while C-reactive protein (CRP) and serum uric acid were assessed as laboratory indicators relevant to inflammatory and gout-associated processes. Non-steroidal anti-inflammatory drugs (NSAIDs) were used as the principal therapeutic intervention. The findings showed a marked reduction in pain following treatment. The mean baseline pain score was 8.2 ± 1.1 and declined to 3.4 ± 1.0 after treatment, representing a statistically significant improvement (p < 0.001). Forty-five patients (90%) were classified as clinically improved, whereas five patients (10%) did not demonstrate comparable improvement. The clinical response was particularly consistent with acute inflammatory presentations such as early gout-related arthritis and reactive or post-infectious inflammatory arthritis. These observations suggest that early recognition, appropriate laboratory assessment, and timely anti-inflammatory management may provide an important opportunity to prevent persistent symptoms and functional deterioration. However, the findings should be interpreted within the limitations of the observational design, relatively small sample size, female-only population, and short-term assessment. Further studies involving larger and more diverse patient populations are required to determine long-term remission, recurrence, and structural outcomes.